Summary: This ADC product is comprised of an anti-CD70 monoclonal antibody conjugated via a VC linker to a rachelmycin. The rachelmycin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, rachelmycin binds to DNA, causes DNA damage. https://www.creative-biolabs.com/adc/target-cd70-14.htm